6-Azauridine
6-Azauridine
6-Azauridine
Thermo Scientific Chemicals

6-Azauridine

CAS: 54-25-1 | C8H11N3O6 | 245.191 g/mol
製品番号(カタログ番号) J61309.06
または、製品番号J61309-06
価格(JPY)
-
数量:
5 g
一括またはカスタム形式をリクエストする
仕様
CAS54-25-1
ChEBICHEBI:35668
化学物質名または材質6-Azauridine
White
EINECS番号200-199-6
さらに表示
6-Azauridine can be applied in antiviral studies. 6-azauridine inhibits de novo pyrimidine synthesis and DNA synthesis and is converted intracellularly into mono, di, and triphosphate derivatives, which incorporate into RNA and inhibit protein synthesis. It is also used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
6-Azauridine can be applied in antiviral studies. 6-azauridine inhibits de novo pyrimidine synthesis and DNA synthesis and is converted intracellularly into mono, di, and triphosphate derivatives, which incorporate into RNA and inhibit protein synthesis. It is also used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic.

Solubility
It is soluble in water.

Notes
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: 2 - 8°C
RUO – Research Use Only

General References:

  1. Rada B.; Dragún M. Antiviral action and selectivity of 6-azauridine. Ann N Y Acad Sci. 1977, 284, 410-7.
  2. JM Crance.; N Scaramozzino.; A Jouan.; D Garin. Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antiviral research. 2003, 58, (1), 73-79.